Article (Scientific journals)
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial
Labar, Boris; Suciu, Stefan; Zittoun, Robert et al.
2004In Haematologica, 89 (7), p. 809-817
Peer Reviewed verified by ORBi
 

Files


Full Text
204.pdf
Publisher postprint (322.3 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
allogeneic stem cell transplantation; ALL
Abstract :
[en] Background and Objectives. In the EORTC ALL-3 trial, the efficacy of allogeneic transplantation was compared with that of autologous marrow transplantation and maintenance chemotherapy in patients less than or equal to 50 years who reached CR. Design and Methods. Among 340 patients who entered the study, 279 were less than or equal to 50 years old. Out of these, 220 reached CR, 184 patients started consolidation and were HLA typed; 68 had a donor and 116 had no sibling donor. The median follow-up was 9.5 years; 93 patients relapsed, 26 died in CR, and overall 116 patients died. Allogeneic transplantation was performed in 47 (68%) patients with a donor while autologous transplantation or maintenance chemotherapy was given to 84 (72%) patients without a sibling donor. Results. The 6-year disease-free survival rate was similar in the groups with and without donor [38.2% (SE=5.9%) vs. 36.8% (SE=4.6%), hazard ratio 1.01, 95% CI 0.67-1.53]. Comparing the donor group with the no donor group, the former had a lower relapse incidence (38.2% vs. 56.3%, p=0.001), but a higher cumulative incidence of death in CR (23.5% vs. 6.9%, p=0.0004). The 6-year survival rates were similar [41.2% (SE=6.0%) vs. 38.8% (SE=4.6%)]. Interpretation and Conclusions. This trial did not show that allogeneic transplantation, when a sibling donor is available, produces a better outcome than the policy of offering autotransplantation or chemotherapy in the absence of a donor.
Disciplines :
Hematology
Author, co-author :
Labar, Boris
Suciu, Stefan
Zittoun, Robert
Muus, Petra
Marie, Jean-Pierre
Fillet, Georges ;  Université de Liège - ULiège > Département des sciences cliniques > Hématologie - Oncologie médicale
Peetermans, Marc
Stryckmans, Pierre
Willemze, Roel
Feremans, Walter
Jaksic, Branimir
Bourhis, Jean-Henir
Burghouts, Jean-Pierre
De Witte, Theo
More authors (4 more) Less
Language :
English
Title :
Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients <= 50 years old in first complete remission: results of the EORTC ALL-3 trial
Publication date :
July 2004
Journal title :
Haematologica
ISSN :
0390-6078
eISSN :
1592-8721
Publisher :
Ferrata Storti Foundation
Volume :
89
Issue :
7
Pages :
809-817
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 31 March 2009

Statistics


Number of views
171 (3 by ULiège)
Number of downloads
319 (0 by ULiège)

Scopus citations®
 
83
Scopus citations®
without self-citations
74

Bibliography


Similar publications



Contact ORBi